Sciatic Aide

Arsenic Trioxide, Chamomile, Citrullus Colocynthis Fruit Pulp, Sulfur

Schwabe North America, Inc
Human Otc Drug
NDC 53499-2798

Sciatic Aide also known as Arsenic Trioxide, Chamomile, Citrullus Colocynthis Fruit Pulp, Sulfur is a human otc drug labeled by 'Schwabe North America, Inc'. National Drug Code (NDC) number for Sciatic Aide is 53499-2798. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Sciatic Aide drug includes Arsenic Trioxide - 12 [hp_X]/1 Chamomile - 3 [hp_X]/1 Citrullus Colocynthis Fruit Pulp - 3 [hp_X]/1 Sulfur - 6 [hp_X]/1 . The currest status of Sciatic Aide drug is Active.

Drug Information:

Drug NDC:	53499-2798
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Sciatic Aide
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Arsenic Trioxide, Chamomile, Citrullus Colocynthis Fruit Pulp, Sulfur
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Schwabe North America, Inc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Tablet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ARSENIC TRIOXIDE - 12 [hp_X]/1 CHAMOMILE - 3 [hp_X]/1 CITRULLUS COLOCYNTHIS FRUIT PULP - 3 [hp_X]/1 SULFUR - 6 [hp_X]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	SUBLINGUAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	18 Aug, 2011
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	30 Jun, 2027
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	16 Jan, 2025
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Schwabe North America, Inc
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UPC:	0308078127989
UPC stands for Universal Product Code.
UNII:	S7V92P67HO FGL3685T2X 23H32AOH17 70FD1KFU70
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
53499-2798-2	1 BOTTLE, GLASS in 1 BOX (53499-2798-2) / 100 TABLET in 1 BOTTLE, GLASS	18 Aug, 2011	30 Jun, 2027	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Sciaticaide

Arsenic Trioxide, Chamomile, Citrullus Colocynthis Fruit Pulp, Sulfur

Tablet
Schwabe Mexico S.A. de C.V.
NDC: 68466-2798

Sciatic Aide

Arsenic Trioxide, Chamomile, Citrullus Colocynthis Fruit Pulp, Sulfur

Tablet
Schwabe North America, Inc
NDC: 53499-2798

Purpose:

Purpose for the temporary relief of minor sciatica pains and aches.

Product Elements:

Sciatic aide arsenic trioxide, chamomile, citrullus colocynthis fruit pulp, sulfur arsenic trioxide arsenic cation (3+) chamomile chamomile citrullus colocynthis fruit pulp citrullus colocynthis fruit pulp sulfur sulfur magnesium stearate lactose monohydrate cellulose, microcrystalline b;t bt b;t

Indications and Usage:

Indications & usage for the temporary relief of minor sciatica pains and aches.

Warnings:

Warning do not take this product for pain for more than 10 days unless directed by a doctor.

Dosage and Administration:

Dosage & administration sublingual medication: place tablets under tongue at least 15 mnutes before or half our after eating, brushing teeth, or drinking anything but water. adults and children 12 years of age: 2 tablets every two hours until relieved. children under 12 years of age: consult a doctor.

Stop Use:

Stop use stop use and ask a docitor if pain persists, gets worse, is accompanied by fever, is prominent while lying down, or if new symptoms occur, or redness or swelling is present. these could be signs of a serious condition.

Overdosage:

Overdose in case of overdose, seek medical help or contact a poison control center immediately.

Package Label Principal Display Panel:

21812798 sciaticaide_6.jpg

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.